These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33031595)

  • 21. Analysis of oxidative stress status, catalase and catechol-O-methyltransferase polymorphisms in Egyptian vitiligo patients.
    Mehaney DA; Darwish HA; Hegazy RA; Nooh MM; Tawdy AM; Gawdat HI; El-Sawalhi MM
    PLoS One; 2014; 9(6):e99286. PubMed ID: 24915010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients.
    Karaca N; Ozturk G; Gerceker BT; Turkmen M; Berdeli A
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e85-90. PubMed ID: 22429552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population.
    Singh M; Mansuri MS; Jadeja SD; Marfatia YS; Begum R
    Indian J Dermatol Venereol Leprol; 2018; 84(3):285-291. PubMed ID: 29620037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association study between keratinocyte-derived growth factor gene polymorphisms and susceptibility to vitiligo vulgaris in a Taiwanese population: potential involvement of stem cell factor.
    Lan CC; Ko YC; Tu HP; Wu CS; Lee CH; Wu CS; Yu HS
    Br J Dermatol; 2009 Jun; 160(6):1180-7. PubMed ID: 19416273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
    Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
    Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the relation between two common cyclooxygenase 2 gene polymorphisms with risk of developing and subtypes of vitiligo in Egyptian patients.
    Salem SAM; Aly DG; Amr KS; Abdel-Hamid MF
    Indian J Dermatol Venereol Leprol; 2018; 84(6):696-700. PubMed ID: 29094684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of human beta-defensin 1 gene polymorphisms with nonsegmental vitiligo.
    Ochoa-Ramírez LA; Becerra-Loaiza DS; Díaz-Camacho SP; Muñoz-Estrada VF; Ríos-Burgueño ER; Prado-Montes de Oca E; Rangel-Villalobos H; Velarde-Félix JS
    Clin Exp Dermatol; 2019 Apr; 44(3):277-282. PubMed ID: 29923320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients.
    Jin SY; Park HH; Li GZ; Lee HJ; Hong MS; Park HJ; Park HK; Seo JC; Yim SV; Chung JH; Lee MH
    J Dermatol Sci; 2004 Sep; 35(3):181-6. PubMed ID: 15381239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo.
    Al-Harthi F; Zouman A; Arfin M; Tariq M; Al-Asmari A
    Genet Mol Res; 2013 Jul; 12(3):2196-204. PubMed ID: 23884763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
    Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
    Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India.
    Jahan P; Cheruvu R; Tippisetty S; Komaravalli PL; Valluri V; Ishaq M
    J Am Acad Dermatol; 2013 Aug; 69(2):262-6. PubMed ID: 23498308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Angiotensin-Converting Enzyme ACE Gene Polymorphism with ACE Activity and Susceptibility to Vitiligo in Egyptian Population.
    Badran DI; Nada H; Hassan R
    Genet Test Mol Biomarkers; 2015 May; 19(5):258-63. PubMed ID: 25807210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between catalase gene polymorphism (T/C exon 9) and susceptibility to vitiligo in a Turkish population.
    Bulut H; Pehlivan M; Alper S; Tomatir AG; Onay H; Yüksel SE; Ozkinay F; Pehlivan S
    Genet Mol Res; 2011 Oct; 10(4):4126-32. PubMed ID: 22058000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of genetic variation in vitiligo associated genes: Population genomics perspective.
    Bharti N; Banerjee R; Achalare A; Kasibhatla SM; Joshi R
    BMC Genom Data; 2024 Jul; 25(1):72. PubMed ID: 39060965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
    Giri PS; Patel S; Begum R; Dwivedi M
    Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Nod-like receptor protein-1 (rs2670660) and Toll-like receptor-4 (rs4986790) with non-segmental vitiligo: A case-control study in South Indian population.
    Rajendiran KS; Rajappa M; Chandrashekar L; Thappa DM
    Int J Immunogenet; 2019 Oct; 46(5):321-330. PubMed ID: 31293094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between IL4 (-590), ACE (I)/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo.
    Pehlivan S; Ozkinay F; Alper S; Onay H; Yuksel E; Pehlivan M; Ozkinay C
    Eur J Dermatol; 2009; 19(2):126-8. PubMed ID: 19129082
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    A T; G O; Tb G; E K; H O; Sm G; O C
    Balkan J Med Genet; 2017 Dec; 20(2):67-74. PubMed ID: 29876235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalase but not vitamin D receptor gene polymorphisms are associated with nonsegmental vitiligo in Northwestern Mexicans.
    Ochoa-Ramírez LA; Díaz-Camacho SP; Becerra-Loaiza DS; Verdugo-Nieto L; Muñoz-Estrada VF; Servín-Vázquez LA; Osuna-Ramírez I; Rodríguez-Millán J; Velarde-Félix JS
    Int J Dermatol; 2019 Nov; 58(11):1264-1269. PubMed ID: 31120146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.